For more information about Cleveland Clinic's Neurofibromatosis Program, please visit https://cle.clinic/3NQi7Kz This year’s Neurofibromatosis Symposium offers patients and family members an opportunity to gain a better understanding of the management of neurofibromatosis and schwannomatosis. New treatments are changing the future of neurofibromatosis care. Neuro-oncologist Dr. Alyssa Lucas explains how targeted therapies and clinical trials are helping improve treatment options for NF1, NF2-related schwannomatosis and related tumors. She also discusses the importance of multidisciplinary care, quality of life and the future of personalized treatment for patients and families living with these conditions. To learn more about Dr. Lucas, please visit https://cle.clinic/4tsGYTv Like this video? Hit like and subscribe for more! #clevelandclinic #neurofibromatosis #schwannomatosis

Sleep Apnea 101: Symptoms, Risks & Solutions | Aparna Bhat, MD
98 views

How Your Nose Works
139 views

Updates in the Diagnosis & Management of Liver Tumors (Graphic)
161 views

4 Myths About Bipolar Disorder
266 views

Cardiac Electrophysiologist Justin Lee, MD
119 views

Deep Brain Stimulation: What To Expect
269 views